# Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents; Confirmation of Effective Date
> **Food and Drug Administration** · Direct final rule; confirmation of effective date. · Published 2001-04-23 · Effective 2001-06-11 · 66 FR 20402
## Document
- **Document number:** 01-9873
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 20402
- **CFR reference:** 21 CFR 660
- **Publication date:** 2001-04-23
- **Effective date:** 2001-06-11
- **HHS docket:** Docket No. 00N-1586
## Abstract

The Food and Drug Administration (FDA) is confirming the effective date of June 11, 2001, for the direct final rule that appeared in the Federal Register of December 12, 2000 (65 FR 77497). The direct final rule rule amends the biologics regulations applicable to microbiological controls for licensed Anti-Human Globulin and Blood Grouping Reagents by removing the requirement that these products be sterile. This document confirms the effective date of the direct final rule.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/04/23/01-9873/revision-to-requirements-for-licensed-anti-human-globulin-and-blood-grouping-reagents-confirmation)
---
*AI Analytics · CC0 1.0*